Does FLECAINIDE Cause Dacryostenosis acquired? 8 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Dacryostenosis acquired have been filed in association with FLECAINIDE (Flecainide Acetate). This represents 0.2% of all adverse event reports for FLECAINIDE.
8
Reports of Dacryostenosis acquired with FLECAINIDE
0.2%
of all FLECAINIDE reports
0
Deaths
8
Hospitalizations
How Dangerous Is Dacryostenosis acquired From FLECAINIDE?
Of the 8 reports, 8 (100.0%) required hospitalization.
Is Dacryostenosis acquired Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FLECAINIDE. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does FLECAINIDE Cause?
Toxicity to various agents (676)
Drug ineffective (437)
Bradycardia (327)
Electrocardiogram qrs complex prolonged (324)
Hypotension (299)
Atrial fibrillation (278)
Electrocardiogram qt prolonged (258)
Cardiac arrest (252)
Completed suicide (223)
Ventricular tachycardia (221)
What Other Drugs Cause Dacryostenosis acquired?
DOCETAXEL (218)
DOCETAXEL\DOCETAXEL ANHYDROUS (84)
TRASTUZUMAB (71)
CYCLOPHOSPHAMIDE (62)
DUPILUMAB (57)
PERTUZUMAB (56)
CARBOPLATIN (49)
ADALIMUMAB (43)
NETARSUDIL (30)
LIFITEGRAST (26)
Which FLECAINIDE Alternatives Have Lower Dacryostenosis acquired Risk?
FLECAINIDE vs FLIBANSERIN
FLECAINIDE vs FLOLAN
FLECAINIDE vs FLUCICLOVINE F-18
FLECAINIDE vs FLUCLOXACILLIN
FLECAINIDE vs FLUCONAZOLE